
The president called out GLP-1 agonists for costing more money in the US compared with other countries

The president called out GLP-1 agonists for costing more money in the US compared with other countries

Millions of people are now taking the likes of Ozempic and Mounjaro

Experts warning people could pile the weight back on within eight weeks

More medical professionals are talking about potential benfits of skinny jabs

The man turned to ChatGPT for medical guidance